• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Sumitomo Corporation entered into contract with Revorf

    INDPHARMAPOST

    Setsuro Tech gets access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan

    BIOSPECTRUMASIA

    Sumitomo Chemical accelerates next-gen biz utilizing synthetic biology

    BIOSPECTRUMASIA

    Sumitomo subsidiary flashes new way of treating schizophrenia in PhII trial

    COM

    Poxel, Sumitomo Pharma Announce +Ve Phase 3 Results from TIMES 2 Trial

    BUSINESSWIRE

    Rentschler Biopharma reveals push for expanding operation in Japan

    MANUFACTURING

    Sumitomo Corporation Acquires Ownership Of Paris Distributor SACI-CFPA; Expands Global Footprint In Personal Care Market

    PR NEWSWIRE

    Sumitomo (SHI) Demag syncs ejector with medical mould movement

    MANUFACTURING CHEMIST

    Japan permits Toray’s Additional Indication of Pruritus Treatment Drug

    BIOSPECTRUM ASIA

    Takeda, Orexigen end CV study for obesity drug Contrave

    FIERCE PHARMA ASIA

    Sumitomo Dainippon says Latuda for schizophrenia in Japan misses PhIII aims

    FIERCE PHARMA ASIA

    Pharma DTC Spending Jumps Almost 21% In 2014

    MM&M

    Allegro Ophthalmics and Hanmi Pharmaceutical Announce Strategic Investment and Collaboration to Develop and Market Luminate in the Republic of Korea and China

    ALLEGRO OPHTHALMICS LLC

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.